Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Informatics and Decision Making
Published in: BMC Medical Informatics and Decision Making 1/2023

Open Access 01-12-2023 | Research

MNCLCDA: predicting circRNA-drug sensitivity associations by using mixed neighbourhood information and contrastive learning

Authors: Guanghui Li, Feifan Zeng, Jiawei Luo, Cheng Liang, Qiu Xiao

Published in: BMC Medical Informatics and Decision Making | Issue 1/2023

Login to get access

Abstract

Background

circRNAs play an important role in drug resistance and cancer development. Recently, many studies have shown that the expressions of circRNAs in human cells can affect the sensitivity of cells to therapeutic drugs, thus significantly influencing the therapeutic effects of these drugs. Traditional biomedical experiments required to verify this sensitivity relationship are not only time-consuming but also expensive. Hence, the development of an efficient computational approach that can accurately predict the novel associations between drug sensitivities and circRNAs is a crucial and pressing need.

Methods

In this research, we present a novel computational framework called MNCLCDA, which aims to predict the potential associations between drug sensitivities and circRNAs to assist with medical research. First, MNCLCDA quantifies the similarity between the given drug and circRNA using drug structure information, circRNA gene sequence information, and GIP kernel information. Due to the existence of noise in similarity information, we employ a preprocessing approach based on random walk with restart for similarity networks to efficiently capture the useful features of circRNAs and drugs. Second, we use a mixed neighbourhood graph convolutional network to obtain the neighbourhood information of nodes. Then, a graph-based contrastive learning method is used to enhance the robustness of the model, and finally, a double Laplace-regularized least-squares method is used to predict potential circRNA-drug associations through the kernel matrices in the circRNA and drug spaces.

Results

Numerous experimental results show that MNCLCDA outperforms six other advanced methods. In addition, the excellent performance of our proposed model in case studies illustrates that MNCLCDA also has the ability to predict the associations between drug sensitivity and circRNA in practical situations.

Conclusions

After a large number of experiments, it is illustrated that MNCLCDA is an efficient tool for predicting the potential associations between drug sensitivities and circRNAs, thereby can provide some guidance for clinical trials.
Literature
1.
Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–65.CrossRefPubMed
2.
Wang L, Wong L, You ZH, et al. NSECDA: natural semantic enhancement for circRNA-disease association prediction. IEEE J Biomed Health Inform. 2022;26(10):5075–84.CrossRefPubMed
3.
Fanale D, Taverna S, Russo A, et al. Circular RNA in exosomes. Circular RNAs: biogenesis and functions, 2018: 109–117.
4.
Xu S, Zhou LY, Ponnusamy M, et al. A comprehensive review of circRNA: from purification and identification to disease marker potential. PeerJ. 2018;6: e5503.CrossRefPubMedPubMedCentral
5.
Panda AC, De S, Grammatikakis I, et al. High-purity circular RNA isolation method (RPAD) reveals vast collection of intronic circRNAs. Nucleic Acids Res. 2017;45(12):e116–e116.CrossRefPubMedPubMedCentral
6.
7.
Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–8.CrossRefPubMed
8.
Syvänen AC. Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet. 2001;2(12):930–42.CrossRefPubMed
9.
10.
11.
Bahn JH, Zhang Q, Li F, et al. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 2015;61(1):221–30.CrossRefPubMed
12.
13.
Joseph NA, Chiou SH, Lung Z, et al. The role of HGF-MET pathway and CCDC66 cirRNA expression in EGFR resistance and epithelial-to-mesenchymal transition of lung adenocarcinoma cells. J Hematol Oncol. 2018;11(1):1–14.CrossRef
14.
Shang J, Chen WM, Liu S, et al. CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy. Leuk Res. 2019;85: 106198.CrossRefPubMed
15.
Zhang H, Yan J, Lang X, et al. Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt/β-catenin signaling pathway. Oncol Lett. 2018;16(5):5856–62.PubMedPubMedCentral
16.
Ruan H, Xiang Y, Ko J, et al. Comprehensive characterization of circular RNAs in~ 1000 human cancer cell lines. Genome Med. 2019;11:1–14.CrossRef
17.
Deng L, Liu Z, Qian Y, et al. Predicting circRNA-drug sensitivity associations via graph attention auto-encoder. BMC Bioinformatics. 2022;23(1):1–15.CrossRef
18.
Yang B, Chen H. Predicting circRNA-drug sensitivity associations by learning multimodal networks using graph auto-encoders and attention mechanism. Brief Bioinform. 2023; 24(1): bbac596.
19.
Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012;41(D1):D955–61.CrossRefPubMedPubMedCentral
20.
Rangwala SH, Kuznetsov A, Ananiev V, et al. Accessing NCBI data using the NCBI sequence viewer and genome data viewer (GDV). Genome Res. 2021;31(1):159–69.CrossRefPubMedPubMedCentral
21.
Wang Y, Bryant SH, Cheng T, et al. Pubchem bioassay: 2017 update. Nucleic Acids Res. 2017;45(D1):D955–63.CrossRefPubMed
22.
Levenshtein V I. Binary codes capable of correcting deletions, insertions, and reversals[C]//Soviet physics doklady. 1966; 10(8): 707–710.
23.
Landrum G. RDKit: A software suite for cheminformatics, computational chemistry, and predictive modeling. Greg Landrum. 2013;8:1–31.
24.
Shen L, Liu F, Huang L, et al. VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares. Comput Biol Med. 2022;140:105119.CrossRef
25.
Niu M, Zou Q, Wang C. GMNN2CD: identification of circRNA–disease associations based on variational inference and graph Markov neural networks. Bioinformatics. 2022;38(8):2246–53.CrossRefPubMed
26.
Li Z, Li J, Nie R, et al. A graph auto-encoder model for miRNA-disease associations prediction. Brief Bioinform. 2021;22(4):bbaa240.
27.
Zhang Y, Lei X, Fang Z, et al. CircRNA-disease associations prediction based on metapath2vec++ and matrix factorization. Big Data Min Anal. 2020;3(4):280–91.CrossRef
28.
Jain DK, Zhang Z, Huang K. Random walk-based feature learning for micro-expression recognition. Pattern Recogn Lett. 2018;115:92–100.CrossRef
29.
Grover A, Leskovec J. node2vec: Scalable feature learning for networks[C]//Proceedings of the 22nd ACM SIGKDD international conference on Knowledge discovery and data mining. 2016: 855–864.
30.
Long Y, Wu M, Kwoh CK, et al. Predicting human microbe–drug associations via graph convolutional network with conditional random field. Bioinformatics. 2020;36(19):4918–27.CrossRefPubMed
31.
Li G, Lin Y, Luo J, et al. GGAECDA: Predicting circRNA-disease associations using graph autoencoder based on graph representation learning. Comput Biol Chem. 2022;99.CrossRefPubMed
32.
Köhler S, Bauer S, Horn D, et al. Walking the interactome for prioritization of candidate disease genes. Am J Human Genetics. 2008;82(4):949–58.CrossRef
33.
34.
Mudiyanselage TB, Lei X, Senanayake N, et al. Predicting CircRNA disease associations using novel node classification and link prediction models on graph convolutional networks. Methods. 2022;198:32–44.CrossRef
35.
Tang X, Luo J, Shen C, et al. Multi-view multichannel attention graph convolutional network for miRNA–disease association prediction. Brief Bioinform. 2021; 22(6): bbab174.
36.
37.
Abu-El-Haija S, Perozzi B, Kapoor A, et al. Mixhop: Higher-order graph convolutional architectures via sparsified neighborhood mixing[C]//international conference on machine learning. PMLR. 2019: 21–29.
38.
Wang J, Liang J, Cui J, et al. Semi-supervised learning with mixed-order graph convolutional networks. Inf Sci. 2021;573:171–81.CrossRef
39.
Belkin M, Niyogi P, Sindhwani V. Manifold regularization: A geometric framework for learning from labeled and unlabeled examples. J Machine Learn Res. 2006;7(11):2399–34.
40.
Zhao C, Liu S, Huang F, et al. CSGNN: Contrastive Self-Supervised Graph Neural Network for Molecular Interaction Prediction[C]//IJCAI. 2021: 3756–3763.
41.
Ruan X, Jiang C, Lin P, et al. MSGCL: inferring miRNA–disease associations based on multi-view self-supervised graph structure contrastive learning. Briefings in Bioinformatics. 2023; 24(2): bbac623.
42.
Velickovic P, Fedus W, Hamilton WL, et al. Deep graph infomax. ICLR (Poster). 2019;2(3):4.
43.
44.
Glorot X, Bengio Y. Understanding the difficulty of training deep feedforward neural networks[C]//Proceedings of the thirteenth international conference on artificial intelligence and statistics. JMLR Workshop and Conference Proceedings, 2010: 249–256.
45.
Yu Z, Huang F, Zhao X, et al. Predicting drug–disease associations through layer attention graph convolutional network. Brief Bioinform. 2021; 22(4): bbaa243.
46.
Yang H, Ding Y, Tang J, et al. Inferring human microbe–drug associations via multiple kernel fusion on graph neural network. Knowl-Based Syst. 2022;238.CrossRef
47.
Ma Z, Kuang Z, Deng L. CRPGCN: predicting circRNA-disease associations using graph convolutional network based on heterogeneous network. BMC Bioinformatics. 2021;22(1):1–23.CrossRef
48.
Shi Z, Zhang H, Jin C, et al. A representation learning model based on variational inference and graph autoencoder for predicting lncRNA-disease associations. BMC Bioinformatics. 2021;22(1):1–20.CrossRef
49.
Wang L, Wong L, Li Z, et al. A machine learning framework based on multi-source feature fusion for circRNA-disease association prediction. Brief Bioinform. 2022; 23(5): bbac388.
50.
Rees MG, Seashore-Ludlow B, Cheah JH, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12(2):109–16.CrossRefPubMed
51.
Wang Y, Chang J, Liu X, et al. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY). 2016;8(11):2915.CrossRefPubMed
52.
Bezerra DP, Pessoa C, de Moraes MO, et al. Overview of the therapeutic potential of piplartine (piperlongumine). Eur J Pharm Sci. 2013;48(3):453–63.CrossRefPubMed
53.
54.
Chow LQM, Eckhardt SG. Sunitinib: from rational design to clinical efficacy. J Clin Oncol. 2007;25(7):884–96.CrossRefPubMed
55.
Mujtaba T, Dou QP. Advances in the understanding of mechanisms and therapeutic use of bortezomib. Discov Med. 2011;12(67):471.PubMedPubMedCentral
56.
Bareschino M A, Schettino C, Troiani T, et al. Erlotinib in cancer treatment. Ann Oncology. 2007; 18: vi35-vi41.
Metadata
Title
MNCLCDA: predicting circRNA-drug sensitivity associations by using mixed neighbourhood information and contrastive learning
Authors
Guanghui Li
Feifan Zeng
Jiawei Luo
Cheng Liang
Qiu Xiao
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2023
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-023-02384-0

Other articles of this Issue 1/2023

BMC Medical Informatics and Decision Making 1/2023 Go to the issue

Research

Research on the doctors’ win in crowdsourcing competitions: perspectives on service content and competitive environment

Research

MRI-based brain tumor detection using convolutional deep learning methods and chosen machine learning techniques

Research

Design, implementation, and evaluation of the computer-aided clinical decision support system based on learning-to-rank: collaboration between physicians and machine learning in the differential diagnosis process

Research

A universal diagnosis syntax

Research article

A study on predicting the length of hospital stay for Chinese patients with ischemic stroke based on the XGBoost algorithm

Research

Impact of clinical decision support on controlled substance prescribing